CCMs arise from the endothelial gain of MEKK3-KLF2/4 signaling, while MAP3K3 and CCM gene mutations both activate the MEKK3-KLF2/4 signaling pathway (13, 15, 16). Here, KLF2 is linked to cerebrocostomandibular syndrome.